Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.

Bockmayr M, Harnisch K, Pohl LC, Schweizer L, Mohme T, Körner M, Alawi M, Suwala AK, Dorostkar MM, Monoranu CM, Hasselblatt M, Wefers AK, Capper D, Hench J, Frank S, Richardson TE, Tran I, Liu E, Snuderl M, Engertsberger L, Benesch M, von Deimling A, Obrecht D, Mynarek M, Rutkowski S, Glatzel M, Neumann JE, Schüller U

Open source

DOI: 10.1093/neuonc/noac088
Published: 2022 Oct 3
Container: Neuro-oncology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noac088,
  title = {Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.},
  author = {Bockmayr M and Harnisch K and Pohl LC and Schweizer L and Mohme T and Körner M and Alawi M and Suwala AK and Dorostkar MM and Monoranu CM and Hasselblatt M and Wefers AK and Capper D and Hench J and Frank S and Richardson TE and Tran I and Liu E and Snuderl M and Engertsberger L and Benesch M and von Deimling A and Obrecht D and Mynarek M and Rutkowski S and Glatzel M and Neumann JE and Schüller U},
  year = {2022},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noac088},
  url = {https://doi.org/10.1093/neuonc/noac088}
}

RIS

TY  - JOUR
TI  - Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.
AU  - Bockmayr M
AU  - Harnisch K
AU  - Pohl LC
AU  - Schweizer L
AU  - Mohme T
AU  - Körner M
AU  - Alawi M
AU  - Suwala AK
AU  - Dorostkar MM
AU  - Monoranu CM
AU  - Hasselblatt M
AU  - Wefers AK
AU  - Capper D
AU  - Hench J
AU  - Frank S
AU  - Richardson TE
AU  - Tran I
AU  - Liu E
AU  - Snuderl M
AU  - Engertsberger L
AU  - Benesch M
AU  - von Deimling A
AU  - Obrecht D
AU  - Mynarek M
AU  - Rutkowski S
AU  - Glatzel M
AU  - Neumann JE
AU  - Schüller U
PY  - 2022
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noac088
UR  - https://doi.org/10.1093/neuonc/noac088
ER  -

APA

M, B., K, H., LC, P., L, S., T, M., M, K., M, A., AK, S., MM, D., CM, M., M, H., AK, W., D, C., J, H., S, F., TE, R., I, T., E, L., M, S., L, E., M, B., A, V. D., D, O., M, M., S, R., M, G., JE, N., & U, S. (2022). Comprehensive profiling of myxopapillary ependymomas identifies a distinct molecular subtype with relapsing disease.. Neuro-oncology. https://doi.org/10.1093/neuonc/noac088

Source records

pubmed · retrieved 2026-09-26T21:46:58.083Z